You searched for "reconstructive"
Choroidal changes after horizontal strabismus surgery
The aim of this study was to investigate choroidal changes in the short-term by looking at the choroidal vascular layer after horizontal strabismus surgery. This was a retrospective study of 27 patients: 12 females and 15 males with mean age...Predicting visual prognosis of patients with methanol poisoning
4 February 2025
| Jonathan Chan
|
EYE - Neuro-ophthalmology
Symptoms of methanol poisoning often occur 12–24 hours after oral consumption, and visual symptoms are seen in approximately 50% of cases. This study aims to investigate the role of optic nerve diffusion status on cranio-orbital magnetic resonance imaging (MRI) in...
Risks for ROP development in mid and late preterm infants
The authors evaluated the incidence, risk factors and retinopathy of prematurity (ROP) development in mid and late preterm infants born at 32 to <37 weeks of gestational age (GA). This was a retrospective study of 5477 infants: 54.4% male. Overall,...Retrospective analysis on the outcomes of contact lens-associated keratitis in a tertiary centre
30 May 2025
|
EYE - Cataract, EYE - General
This is a retrospective cohort study of 161 eyes (153 patients) with contact lens-associated keratitis (CLAK) from Moorfields Hospital between 1 July 2021 to 28 February 2022. They were classified into three groups based on the size of the epithelial...
How does teprotumumab impact on ocular misalignment in thyroid eye disease?
30 June 2025
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
A retrospective case review was conducted with the aim of exploring the effect of teprotumumab on objective diplopia. Adults diagnosed with thyroid eye disease, presenting with diplopia and receiving a standard six-month treatment with teprotumumab at a single centre were...
How to pass the FRCOphth Part 1 as a foundation trainee: some practical tips
7 February 2022
| Vanessa Yeo
|
EYE - General
Attempting the FRCOphth Part 1 examination as a foundation trainee requires significant time and financial commitment. Unlike the MRCP and MRCS examinations, the curriculum of this exam does not overlap with the undergraduate syllabus. As such, it is a steep...
When science meets art: Creating brilliant sparks
4 February 2025
| Ningli Wang (Prof), Ning Tian, Mayinuer Yusufu
|
EYE - Glaucoma
I was honoured to have the privilege of reconnecting with the Tongren Eye Center team in Beijing, China. Digital art in mainstream media has showcased some glorious works and it is humbling to see and hear about some creative new...
New speaker for the SEE Summit
The Association of British Dispensing Opticians (ABDO) has announced another speaker for the SEE Summit. Former GP Dr Matt Sawyer runs an environmental sustainability consultancy, SEE Sustainability, working to improve human and planetary health.Atlas of Glaucoma Third edition
1 December 2015
| Indira Madgula
|
EYE - Glaucoma
Glaucoma patients constitute a significant proportion of any ophthalmology clinic. Hence, a basic understanding, evaluation and management of the condition form part of the essential clinical skillset of any ophthalmologist. Atlas of Glaucoma is a good read and very useful...
Ocular Telehealth: A Practical Guide, 1st Edition
3 February 2023
| Paras Agarwal
|
EYE - General
Ocular Telehealth: A Practical Guide is in its first edition, which is great considering the recent adjustments to practical medical delivery that the COVID-19 pandemic has mandated. Overall, this book is well written in a structured format defining the uses...
Subfoveal choroidal thickness and PCV
1 April 2018
| Saruban Pasu
|
EYE - Vitreo-Retinal
This report studies the prognostic factors for visual improvement and the need for additional treatments at one year after the initial combination therapy of intravitreal ranibizumab injection or intravitreal aflibercept injection followed by PDT in eyes with PCV. Fifty-six eyes...
Antibiotic prophylaxis after intravitreal injections
1 June 2014
| Brian Ang
|
EYE - General
The use of topical antibiotics as prophylaxis after intravitreal injections is a contentious issue, especially now with increasing use of intravitreal anti-VEGF agents. In the Wills Eye Institute, prior to May 2011, all patients undergoing intravitreal injections in the office...